Click sobre imagen para ampliar
A report released today by Senators Max Baucus, Charles Grassley said Glaxo knew Avandia may cause heart damage several years before a studydocumented the risk and the company pressed doctors to retract warnings about side effects. Baucus, chair of the Senate Finance Committee, and Grassley, the committee’s ranking Republican, are pressing the FDA for answers.
Avandia came on the market in 1999 and achieved annual revenue of $3 billion by 2006, including sales of a combination drug that includes Avandia. Sales plummeted to $1.2 billion in 2009, two years after a studyNew England Journal of Medicine that linked Avandia to a 43 percent increased risk of heart attack. Two was published in the FDA officials also reviewed the drug’s safety and concluded in their 2008 report that Avandia was exposing users to higher risks for heart attacks, or myocardial infarctions, without being any more effective than a rival drug, Tokyo-based Takeda Pharmaceutical Co.’s Actos.(Ver...)
Entradas
No hay comentarios:
Publicar un comentario